About Us

Founded by Doctors
Focused on Patients

Restoring cellular energy deficits at the root of heart disease and inborn errors of metabolism

At Imbria, we are using our deep understanding of energy metabolism to develop novel therapies designed to substantially improve the lives of patients with life-altering diseases. Our clinical stage pipeline is focused on restoring or improving  the cell’s ability to produce energy in disorders where energetic impairment is a fundamental contributor, including cardiovascular disease and specific inborn errors in metabolism.

Our lead program, IMB-101, is currently in Phase 2 clinical development in three indications: Hypertrophic cardiomyopathy, stable angina, and type 2 diabetes at risk for diabetic cardiomyopathy. The pipeline also includes IMB-203, designed to address the energy deficiency in patients with rare inborn errors of mitochondrial metabolism.

  • 20XX

     

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sapien nisi, auctor sit amet dignissim eget.

  • 20XX

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sapien nisi, auctor sit amet dignissim eget.

     

    20XX

  • 20XX

     

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sapien nisi, auctor sit amet dignissim eget.

  • 20XX

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sapien nisi, auctor sit amet dignissim eget.

     

    20XX

  • 20XX

     

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sapien nisi, auctor sit amet dignissim eget.

PATIENTS FIRST

We put patients first.

INTEGRITY

We do what’s right, not what’s easy.

ALL IN, ALL THE TIME

We give everything we have, individually and as a team — patients are counting on us.

RESPECT

We respect every individual and value our differences — in thought, style, culture and experience.